F23. OLANZAPINE-INDUCED PERTURBATIONS OF WHOLE-BODY INSULIN SENSITIVITY MAY OCCUR VIA INACTIVATION OF CENTRAL K-ATP CHANNELS
Notice bibliographique
Résumé
Antipsychotics are the cornerstone of treatment for schizophrenia and are widely prescribed on- and off- label for other mental illnesses. However, antipsychotic use is associated with excessive weight gain (over 75% of youth will gain >7% body weight) and increased risk of type 2 diabetes. Recent work suggests that antipsychotics can immediately and independently of weight gain induce insulin resistance, and that this may occur via the central nervous system (CNS). To this point, we recently published data demonstrating that olanzapine, a highly effective and widely prescribed antipsychotic, abolishes the ability of a CNS insulin infusion to restrain glucose production by the liver in rodents. These data demonstrate that olanzapine inhibits CNS insulin action, but the mechanism is unknown. The ATP-sensitive potassium (KATP) channel is a key metabolic sensor downstream of CNS insulin signaling in the hypothalamus, which is involved the maintenance of energy and glucose homeostasis. In the present study, we set out to determine whether olanzapine in rodents inhibits CNS KATP channel activation to disrupt peripheral glucose metabolism. Sprague Dawley rats underwent intracerebroventricular (ICV) cannulae implantation into the 3rd ventricle, and following a 1-week recovery, underwent jugular and carotid cannulation surgeries. Gold-standard pancreatic euglycemic clamps were then used to measure glucose kinetics. During the clamp procedure, endogenous insulin secretion is inhibited by a somatostatin infusion, and insulin is replaced at basal levels. Glucose is infused at a variable rate to maintain euglycemia, and the glucose infusion rate is a measure of whole-body insulin sensitivity. Additionally, a continuous infusion of a radioactive glucose tracer allows the measurement of glucose uptake and production. Prior to the clamp, rats were also pre-treated with an acute subcutaneous injection of olanzapine (OLA) or vehicle (VEH). A primed, continuous ICV infusion of the KATP channel activator Diazoxide (DIAZ) or vehicle (VEH) was administered throughout the clamp procedure. Groups included (central-peripheral): VEH-VEH (n=6), VEH-OLA (n=4), DIAZ-VEH (n=9), DIAZ-OLA (n=11). The glucose infusion rate needed to maintain euglycemia during the clamp was significantly higher in DIAZ-VEH rats compared to VEH-VEH or VEH-OLA controls, while DIAZ-OLA rats had a significantly decreased glucose infusion rate compared to DIAZ-VEH, indicative of impaired whole-body insulin sensitivity. We replicated previous findings that ICV DIAZ treatment significantly suppresses glucose production, and interestingly this suppression was undisturbed by OLA co-treatment (DIAZ-OLA). Glucose uptake was significantly increased by ICV DIAZ, and this effect was abolished by OLA co-administration (DIAZ-OLA). These data suggest that olanzapine can inhibit central KATP channel activation to perturb whole body insulin sensitivity, via inhibition of glucose uptake. Combining this with our previous findings that olanzapine impairs central insulin-mediated glucose production, olanzapine may act through potential divergent CNS pathways to regulate glucose production and uptake. Regardless, inactivation of KATP channels (a key central metabolic sensor) is a novel mechanism by which antipsychotics could induce diabetes and disrupt energy homeostasis. Given that KATP channels are also involved in CNS interactions of neurotransmitter systems (i.e. dopamine, glutamate), our findings may also have future implications beyond metabolic side-effects of these drugs to effects on psychopathology.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,001 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,001 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,005 | 0,001 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».